Sara Cobb, PA
Physician Assistant · Asheville, NCNPI 1801349279
Payments from drug & device makers
Across 129 payments — averaging $23.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Autolus Inc$800
- Pfizer$225
- Novo Nordisk$220
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$205
- Boehringer Ingelheim$192
- Bayer$178
- plus $1K from 18 others
What the payments were for
- Speaking & faculty fees$80026%
- Food & beverage$2,26874%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Autolus Inc | 1 | $800 |
| Pfizer | 13 | $225 |
| Novo Nordisk | 14 | $220 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $205 |
| Boehringer Ingelheim | 16 | $192 |
| Bayer | 9 | $178 |
| GSK | 8 | $153 |
| Sanofi-aventis U.S. LLC | 5 | $114 |
| Exact Sciences | 5 | $109 |
| Merck | 7 | $107 |
| Lilly USA, LLC | 5 | $98 |
| Amgen | 6 | $98 |
| AbbVie | 5 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $87 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $68 |
| Idorsia Pharmaceuticals US Inc | 4 | $61 |
| Abbott | 3 | $61 |
| Inari Medical, Inc. | 2 | $46 |
| Astellas Pharma US Inc | 2 | $44 |
| AstraZeneca | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Abiomed | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
How this compares
$3,068 in reported general payments places this provider in the 85th percentile of 7,441 physician assistant providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 98 | $123,311 |
| OzempicSemaglutide | 57 | $83,715 |
| JardianceEmpagliflozin | 62 | $83,526 |
| XareltoRivaroxaban | 38 | $46,701 |
| TrulicityDulaglutide | 32 | $35,554 |
| RybelsusSemaglutide | 16 | $31,576 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 40 | $29,043 |
| JanuviaSitagliptin Phosphate | 20 | $24,966 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 16 | $20,050 |
| LinzessLinaclotide | 13 | $17,073 |
| MounjaroTirzepatide | 12 | $12,402 |
| Breo ElliptaFluticasone/Vilanterol | 23 | $11,763 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 19 | $7,894 |
| Wixela InhubFluticasone Propion/Salmeterol | 45 | $6,275 |
| SynthroidLevothyroxine Sodium | 57 | $4,280 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $225 | $123,31198 claims |
| Novo NordiskOzempic, Rybelsus | $220 | $115,29173 claims |
| Boehringer IngelheimJardiance | $192 | $83,52662 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $153 | $48,69982 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $98 | $47,95644 claims |
| Johnson & JohnsonXarelto | $13 | $46,70138 claims |
| MerckJanuvia | $107 | $24,96620 claims |
| AbbVieLinzess, Synthroid | $95 | $21,35370 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $114 | $20,05016 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Asheville
- Jeremy DavidsonAsheville$96K
- John AveretteAsheville$34K
- Carrie VoedischAsheville$32K
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.